HARNESSING SENESCENCE FOR HUMAN HEALTHSPAN

Atropos aims to treat aging-related diseases and cancer and improve healthspan with approved novel senescence- targeting drugs.

NEWS

November 16, 2020

Atropos is one of the companies selected for Nature Biotechnology’s

new article on senolytics. Read more >>

August 13, 2020

We are excited to collaborate with The Estée Lauder Companies

in a joint development agreement to discover senomodulators! >>

Atropos, the Fate whose duty it was to cut the threads of life.

Robert S. Holzman, MD

The Legacy of Atropos, the Fate Who Cut the Thread of Life, 1998